Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
Zhu, Yezi, Dalrymple, Susan L, Coleman, Ilsa, Zheng, S Lilly, Xu, Jianfeng, Hooper, Jody E, Antonarakis, Emmanuel S, De Marzo, Angelo M, Meeker, Alan K, Nelson, Peter S, Isaacs, William B, Denmeade, Samuel R, Luo, Jun, Brennen, W Nathaniel, Isaacs, John T
Published in Oncogene (05.11.2020)
Published in Oncogene (05.11.2020)
Get full text
Journal Article
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
Sena, Laura A, Kumar, Rajendra, Sanin, David E, Thompson, Elizabeth A, Rosen, D Marc, Dalrymple, Susan L, Antony, Lizamma, Yang, Yuhan, Gomes-Alexandre, Carolina, Hicks, Jessica L, Jones, Tracy, Bowers, Kiara A, Eskra, Jillian N, Meyers, Jennifer, Gupta, Anuj, Skaist, Alyza, Yegnasubramanian, Srinivasan, Luo, Jun, Brennen, W Nathaniel, Kachhap, Sushant K, Antonarakis, Emmanuel S, De Marzo, Angelo M, Isaacs, John T, Markowski, Mark C, Denmeade, Samuel R
Published in The Journal of clinical investigation (01.12.2022)
Published in The Journal of clinical investigation (01.12.2022)
Get full text
Journal Article
Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancer
Isaacs, John T, Dalrymple, Susan L, Antony, Lizamma, Marc Rosen, David, Coleman, Ilsa M, Nelson, Peter S, Kostova, Maya, Murray, Iain A, Perdew, Gary H, Denmeade, Samuel R, Akinboye, Emmanuel S, Brennen, W Nathaniel
Published in The Prostate (01.11.2023)
Published in The Prostate (01.11.2023)
Get full text
Journal Article
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer
Nouri, Mannan, Varkaris, Andreas, Ridinger, Maya, Dalrymple, Susan L, Dennehy, Christopher M, Isaacs, John T, Einstein, David J, Brennen, W Nathaniel, Balk, Steven P
Published in Molecular cancer therapeutics (01.10.2024)
Published in Molecular cancer therapeutics (01.10.2024)
Get full text
Journal Article
Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer
Rogers, Oliver C, Antony, Lizamma, Levy, Oren, Joshi, Nitin, Simons, Brian W, Dalrymple, Susan L, Rosen, D Marc, Pickering, Andrew, Lan, Haoyue, Kuang, Heidi, Ranganath, Sudhir H, Zheng, Lei, Karp, Jeffrey M, Howard, S Peter, Denmeade, Samuel R, Isaacs, John T, Brennen, W Nathaniel
Published in Molecular cancer therapeutics (01.11.2020)
Published in Molecular cancer therapeutics (01.11.2020)
Get full text
Journal Article
Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer
Isaacs, John T., D'Antonio, Jason M., Chen, Shuangling, Antony, Lizamma, Dalrymple, Susan P., Ndikuyeze, Georges H., Luo, Jun, Denmeade, Samuel R.
Published in The Prostate (01.10.2012)
Published in The Prostate (01.10.2012)
Get full text
Journal Article
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment
ISAACS, John T, ANTONY, Lizamma, BJÖRK, Per, OLSSON, Anders, BJÖRK, Anders, LEANDERSON, Tomas, DALRYMPLE, Susan L, NATHANIEL BRENNEN, W, GERBER, Stephanie, HAMMERS, Hans, WISSING, Michel, KACHHAP, Sushant, JUN LUO, LI XING
Published in Cancer research (Chicago, Ill.) (15.02.2013)
Published in Cancer research (Chicago, Ill.) (15.02.2013)
Get full text
Journal Article
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models
Jasmine, Sumer, Mandl, Adel, Krueger, Timothy E. G., Dalrymple, Susan L., Antony, Lizamma, Dias, Jennifer, Celatka, Cassandra A., Tapper, Amy E., Kleppe, Maria, Kanayama, Mayuko, Jing, Yuezhou, Speranzini, Valentina, Wang, Yuzhuo Z., Luo, Jun, Trock, Bruce J., Denmeade, Samuel R., Carducci, Michael A., Mattevi, Andrea, Rienhoff, Hugh Y., Isaacs, John T., Brennen, W. Nathaniel
Published in The Prostate (01.07.2024)
Published in The Prostate (01.07.2024)
Get full text
Journal Article
Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy
Denmeade, Samuel R, Mhaka, Annastasiah M, Rosen, D Marc, Brennen, W Nathaniel, Dalrymple, Susan, Dach, Ingrid, Olesen, Claus, Gurel, Bora, Demarzo, Angelo M, Wilding, George, Carducci, Michael A, Dionne, Craig A, Møller, Jesper V, Nissen, Poul, Christensen, S Brøgger, Isaacs, John T
Published in Science translational medicine (27.06.2012)
Published in Science translational medicine (27.06.2012)
Get more information
Journal Article
Correction: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
Zhu, Yezi, Dalrymple, Susan L, Coleman, Ilsa, Zheng, S Lilly, Xu, Jianfeng, Hooper, Jody E, Antonarakis, Emmanuel S, De Marzo, Angelo M, Meeker, Alan K, Nelson, Peter S, Isaacs, William B, Denmeade, Samuel R, Luo, Jun, Brennen, W Nathaniel, Isaacs, John T
Published in Oncogene (03.06.2021)
Published in Oncogene (03.06.2021)
Get full text
Journal Article
Correction to: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
Zhu, Yezi, Dalrymple, Susan L, Coleman, Ilsa, Zheng, S Lilly, Xu, Jianfeng, Hooper, Jody E, Antonarakis, Emmanuel S, De Marzo, Angelo M, Meeker, Alan K, Nelson, Peter S, Isaacs, William B, Denmeade, Samuel R, Luo, Jun, Brennen, W Nathaniel, Isaacs, John T
Published in Oncogene (01.03.2021)
Published in Oncogene (01.03.2021)
Get full text
Journal Article
Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling
D'Antonio, Jason M, Vander Griend, Donald J, Antony, Lizamma, Ndikuyeze, George, Dalrymple, Susan L, Koochekpour, Shahriar, Isaacs, John T
Published in PloS one (08.07.2010)
Published in PloS one (08.07.2010)
Get full text
Journal Article
Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
Brennen, W Nathaniel, Zhu, Yezi, Coleman, Ilsa M, Dalrymple, Susan L, Antony, Lizamma, Patel, Radhika A, Hanratty, Brian, Chikarmane, Roshan, Meeker, Alan K, Zheng, S Lilly, Hooper, Jody E, Luo, Jun, De Marzo, Angelo M, Corey, Eva, Xu, Jianfeng, Yegnasubramanian, Srinivasan, Haffner, Michael C, Nelson, Peter S, Nelson, William G, Isaacs, William B, Isaacs, John T
Published in JCI insight (22.04.2021)
Published in JCI insight (22.04.2021)
Get full text
Journal Article
Pharmacologic Basis for the Enhanced Efficacy of Dutasteride against Prostatic Cancers
Xu, Yi, Dalrymple, Susan L, Becker, Robyn E, Denmeade, Samuel R, Isaacs, John T
Published in Clinical cancer research (01.07.2006)
Published in Clinical cancer research (01.07.2006)
Get full text
Journal Article
Assessing angiogenic responses induced by primary human prostate stromal cells in a three-dimensional fibrin matrix assay
Brennen, W Nathaniel, Nguyen, Huong, Dalrymple, Susan L, Reppert-Gerber, Stephanie, Kim, Jeesun, Isaacs, John T, Hammers, Hans
Published in Oncotarget (01.11.2016)
Published in Oncotarget (01.11.2016)
Get full text
Journal Article